Portfolio of Technologies

miRNAs biomarkers for the prediction and diagnosis of Venous Thrombosis New protein with organ-protective properties against ischemia and subsequent reperfusion of the damaged area Neuropsychological scales specifically designed to assess the performance of subjects with movement disorders FANCONINIB – Targeting DNA repair in cancer therapeutics High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles Protein nano- or microparticles as artificial inclusion bodies for drug delivery